Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoprostenol vs Placebo for Severe Frostbite Injury (ECCO)
NCT07424378Phase 4Not yet recruiting
- Sponsor
- University of Colorado Denver
- Start
- Feb 2026
- Primary completion
- Nov 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in frostbite, sponsored by University of Colorado Denver. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
epoprostenol
03
Conditions
frostbite
Beyond the preview
Go deeper on NCT07424378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424378.